Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase II subunit D (POLR2D), also known as RPB4, is the fourth-largest subunit of the eukaryotic RNA polymerase II complex, responsible for the synthesis of messenger RNA precursors and certain small RNAs from DNA templates. POLR2D forms a heterodimer with RPB7 (POLR2G), which dissociates from the core enzyme under stress or suboptimal conditions and is required for efficient transcript stabilization and proper RNA processing during elongation. Structural studies show POLR2D is vital for RNA recognition, binding nascent RNA near the exit channel, and ensuring transcriptional fidelity. Dysfunction or loss of POLR2D impairs global gene expression and is incompatible with cell viability, with implications for development, disease, and cellular stress response
N/A for this specific subunit (for RNA polymerase II as a whole: inhibition by binding and blocking enzymatic activity; e.g. α-amanitin)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase II subunit D (POLR2D).